1. Definition & Mechanism

Anticholinergics block muscarinic acetylcholine (M1–M5) receptors, inhibiting parasympathetic activity.

  • Central effects → cognition, delirium (esp. M1 blockade)
  • Peripheral effects → ↓ secretions, ↓ GI motility, bronchodilation, mydriasis, urinary retention

Mnemonic: “Hot, Dry, Blind, Red, Mad, Full”

2. Commonly Encountered Anticholinergic Drugs (Hospital-Relevant)

Therapeutic Area Examples
Neurology / Psychiatry Benztropine, Trihexyphenidyl
Respiratory Ipratropium, Tiotropium, Glycopyrrolate
GI / Antispasmodics Dicycloverine (Dicyclomine), Hyoscine (Scopolamine)
Urology Oxybutynin, Tolterodine, Solifenacin
Anesthesia / ICU Atropine, Glycopyrrolate
Ophthalmology Atropine, Tropicamide
Others with anticholinergic burden TCAs, 1st-gen antihistamines, antipsychotics

3. Muscarinic Receptor Selectivity (Clinical Relevance)

Receptor Location Clinical Effect When Blocked
M1 CNS, gastric glands Delirium, cognitive impairment
M2 Heart Tachycardia
M3 Smooth muscle, glands Dry mouth, urinary retention, constipation, mydriasis
M4/M5 CNS Less defined (cognitive effects)

CNS penetration ↑ with tertiary amines (e.g., atropine, oxybutynin)

Quaternary agents (e.g., glycopyrrolate) = minimal CNS effects4. Clinical Indications (Key Hospital Uses)

  • Symptomatic bradycardia → Atropine
  • COPD/asthma → Ipratropium, Tiotropium
  • Extrapyramidal symptoms (EPS) → Benztropine
  • Overactive bladder → Oxybutynin, Solifenacin
  • Secretion control (ICU/palliative) → Glycopyrrolate, Scopolamine
  • Pre-op anesthesia → Reduce secretions, prevent vagal responses

5. Adverse Effects (High-Yield)Peripheral

  • Dry mouth, constipation, ileus
  • Urinary retention (↑ risk in BPH)
  • Tachycardia
  • Hyperthermia (↓ sweating)

Central

  • Confusion, agitation
  • Delirium
  • Hallucinations (elderly, high doses)

Dose-related and cumulative across drug classes6. Anticholinergic Burden (Very Important Clinically)

  • Cumulative effect from multiple drugs
  • Strong predictor of:
    • Delirium
    • Falls
    • Cognitive decline
    • Length of stay

High-risk populations

  • Older adults
  • ICU patients
  • Dementia
  • Renal impairment

Tools:

  • Anticholinergic Cognitive Burden (ACB) Scale
  • Beers Criteria (many anticholinergics = potentially inappropriate)

7. Contraindications & Cautions

Condition Risk
Narrow-angle glaucoma ↑ IOP
BPH / urinary retention Acute retention
Ileus / bowel obstruction Worsening
Dementia Cognitive decline
Myasthenia gravis Symptom exacerbation

8. Renal & Hepatic Considerations (General)

  • Many agents require dose caution in renal impairment
  • CNS effects ↑ in renal/hepatic dysfunction
  • Prefer peripherally selective agents when possible

9. Toxicity & OverdoseAnticholinergic Toxidrome

  • Delirium, hallucinations
  • Hyperthermia
  • Dry skin, mydriasis
  • Tachycardia, urinary retention

Management

  • Supportive care
  • Physostigmine (selected cases, severe delirium, ECG monitoring required)

10. Practical Pharmacist Pearls✔ Always assess total anticholinergic load

✔ Avoid in elderly unless clearly indicated

✔ Prefer targeted or peripherally acting agents

✔ Monitor:

  • Mental status
  • Bowel/bladder function
  • Heart rate
    ✔ Deprescribe when possible

11. Quick One-Line Clinical SummaryAnticholinergics are effective but high-risk medications whose cumulative burden is a major, often preventable cause of delirium, urinary retention, and falls in hospitalized patients—especially older adults.

Anticholinergic burden table, tailored for clinical & hospital pharmacists, using the Anticholinergic Cognitive Burden (ACB) scale (most widely used in inpatient practice).
ACB score
  • 0 = no anticholinergic activity
  • 1 = possible anticholinergic effect
  • 2 = definite anticholinergic effect
  • 3 = strong anticholinergic effect (high delirium/fall risk)

Clinical rule of thumb:

Total ACB ≥ 3 → ↑ risk of delirium, cognitive decline, falls, LOS, mortality.

Anticholinergic Burden Table (Drug-by-Drug)

CNS / Psychiatry

Drug Class ACB Key Clinical Notes
Benztropine Antiparkinsonian 3 High delirium risk; avoid in elderly
Trihexyphenidyl Antiparkinsonian 3 Strong central effects
Amitriptyline TCA 3 Avoid in geriatrics (Beers)
Imipramine TCA 3 High fall & arrhythmia risk
Nortriptyline TCA 2 Less anticholinergic than amitriptyline
Paroxetine SSRI 1 Most anticholinergic SSRI
Clozapine Atypical antipsychotic 1–2 Dose-dependent
Quetiapine Atypical antipsychotic 1 Sedation + anticholinergic load
Olanzapine Atypical antipsychotic 1 ↑ delirium risk in elderly

Respiratory

Drug Class ACB Key Clinical Notes
Ipratropium SAMA 1 Minimal CNS effects (inhaled)
Tiotropium LAMA 1 Preferred over oxybutynin-like agents
Glycopyrrolate (inhaled) LAMA 1 Quaternary → minimal CNS

Urology (Overactive Bladder)

Drug Class ACB Key Clinical Notes
Oxybutynin Antimuscarinic 3 Highest cognitive risk
Tolterodine Antimuscarinic 3 Less CNS than oxybutynin
Solifenacin M3-selective 2–3 Better tolerability
Darifenacin M3-selective 2 Lower CNS penetration
Trospium Quaternary amine 1–2 Preferred in elderly

GI / Antispasmodics

Drug Class ACB Key Clinical Notes
Dicycloverine (Dicyclomine) Antispasmodic 3 Delirium & ileus risk
Hyoscine (Scopolamine) Antispasmodic 3 CNS toxicity common
Atropine Antimuscarinic 3 Acute hospital use only
Glycopyrrolate Antimuscarinic 1 Preferred for secretion control

ENT / Allergy

Drug Class ACB Key Clinical Notes
Diphenhydramine 1st-gen antihistamine 3 Common cause of delirium
Chlorpheniramine 1st-gen antihistamine 3 Avoid in inpatients
Hydroxyzine Antihistamine 3 QT + anticholinergic risk
Loratadine 2nd-gen antihistamine 0 Preferred
Cetirizine 2nd-gen antihistamine 0–1 Mild sedation possible

Cardiovascular / Other

Drug Class ACB Key Clinical Notes
Disopyramide Antiarrhythmic 3 Avoid unless essential
Digoxin Cardiac glycoside 1 Weak anticholinergic
Furosemide Loop diuretic 1 Contributes to cumulative burden
Prednisone Corticosteroid 1 Delirium risk additive

High-Risk Combinations (Common in Hospital)

Pharmacist Clinical Actions

✔ Calculate total ACB score on admission

✔ Flag ACB ≥ 3 during med reconciliation

✔ Substitute with lower-ACB alternatives

✔ Prefer quaternary agents (e.g., glycopyrrolate, trospium)

✔ Monitor delirium, urinary retention, constipation

 
One-Line Clinical Pearl

Anticholinergic burden is cumulative, often unrecognized, and one of the most modifiable medication-related causes of delirium in hospitalized patients.

Practical, drug-by-drug substitution recommendations to reduce anticholinergic burden, written for clinical & hospital pharmacists (geriatric, ICU, medical ward–ready).Focus: maintain indication efficacy while lowering ACB score and delirium risk.

High-Anticholinergic Drugs → Lower-Burden Alternatives

EPS / Parkinsonism

High-ACB Drug ACB Preferred Substitution Rationale / Pharmacist Notes
Benztropine 3 Amantadine Less anticholinergic, effective for EPS
    Dose reduction or PRN use Avoid chronic scheduled use
Trihexyphenidyl 3 Amantadine Lower cognitive toxicity
Pearl: Anticholinergics should not be first-line for antipsychotic-induced EPS in elderly.

Overactive Bladder

High-ACB Drug ACB Preferred Substitution Notes
Oxybutynin 3 Mirabegron β3-agonist, no anticholinergic
    Trospium Quaternary amine → ↓ CNS
Tolterodine 3 Solifenacin M3 selective
    Darifenacin Lowest CNS penetration
Pearl: Mirabegron preferred in dementia, delirium, fall risk.

Respiratory (COPD/Asthma)

High-ACB Drug ACB Preferred Substitution Notes
Oral anticholinergics 2–3 Inhaled LAMA/SAMA ↓ systemic effects
Ipratropium (frequent PRN) 1 Tiotropium Once-daily, better adherence

Inhaled agents = minimal CNS penetration.

GI / Antispasmodics

High-ACB Drug ACB Preferred Substitution Notes
Dicycloverine 3 Peppermint oil IBS symptom relief
    Loperamide (if diarrhea) No anticholinergic
    Non-pharm strategies Diet, fiber
Hyoscine 3 Ondansetron (if nausea) Safer alternative

Allergy / Pruritus / Sleep

High-ACB Drug ACB Preferred Substitution Notes
Diphenhydramine 3 Cetirizine / Loratadine 2nd-gen antihistamines
    Melatonin Sleep aid
    Low-dose trazodone If insomnia
Hydroxyzine 3 Cetirizine Same indication, safer

Diphenhydramine is a top cause of inpatient delirium.

Depression / Anxiety

High-ACB Drug ACB Preferred Substitution Notes
Amitriptyline 3 Sertraline First-line SSRI
    Duloxetine Neuropathic pain + depression
    Gabapentin Neuropathic pain
Paroxetine 1 Escitalopram Lower anticholinergic

Cardiac / Other

High-ACB Drug ACB Preferred Substitution Notes
Disopyramide 3 Alternative antiarrhythmic Rarely justified
Prednisone (delirium) 1 Dose reduction / taper Minimize exposure
Furosemide (polypharmacy) 1 Reassess indication Hidden burden

ICU-Specific Substitutions

Indication Avoid Use Instead Rationale
Secretion control Atropine Glycopyrrolate No CNS penetration
Sedation Diphenhydramine Dexmedetomidine ↓ delirium
Nausea Scopolamine Ondansetron Safer

Pharmacist-Led Deprescribing Algorithm (Quick)

  • 1️⃣ Calculate total ACB score
  • 2️⃣ Identify ACB = 3 drugs first
  • 3️⃣ Substitute with non-anticholinergic or peripherally selective agent
  • 4️⃣ Reassess cognition, bowel, bladder in 24–72 h
  • 5️⃣ Document delirium risk reductionOne-Line Clinical Pearl

Replacing one ACB-3 drug often reduces delirium risk more than stopping multiple low-risk agents.

Anticholinergic Agents